iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Pfizer Q1 PAT tanks 83% YoY to Rs 32 cr

5 Aug 2022 , 04:18 PM

Revenue from operations declined 20.9% year on year to Rs 592.90 crore in the quarter ended 30 June 2022. Profit before tax in Q1 FY23 stood at Rs 43.39 crore, up 83.9% from Rs 268.73 crore recorded in Q1 FY22. Total expenditure declined 12.5% YoY to Rs 431.20 crore during the quarter. Cost of materials consumed skid 4.5% to Rs 90.23 crore and employee benefits expenses slipped 2.3% to Rs 92.20 crore in Q1 FY23 over Q1 FY22. Pfizer is a research-based global biopharmaceutical company which is engaged in the discovery, development and manufacture of healthcare products. Shares of Pfizer closed 0.72% lower to end at Rs 4,230 on the BSE. Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.